Blog
About

4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      MicroRNA-338-3p functions as tumor suppressor in breast cancer by targeting SOX4.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          MicroRNA-338-3p (miR‑338-3p), a recently discovered miRNA, has been reported to be downregulated and play tumor suppressor roles in gastric cancer, ovarian cancer, colorectal carcinoma and lung cancer by targeting several genes. However, the role and potential mechanism of miR‑338-3p in breast cancer (BC) is still unclear. In the present study, we investigated the roles and mechanisms of miR‑338-3p in human breast cancer. miR‑338-3p expression was determined by qRT-PCR in human BC cell lines, and clinical significantly of miR‑338-3p expression was further evaluated. Furthermore, the function of miR‑338-3p in breast cancer also was investigated by several in vitro approaches and in nude mouse models. Luciferase assay and western blot analysis were performed to validate the potential targets of miR‑338-3p after the preliminary screening by employing open access software. It was found that miR‑338-3p was significantly downregulated in both BC tissues and cell lines and the low expression of miR‑338-3p was inversely correlated with lymph node metastatic and TNM stage status (P<0.01). Function assay showed that the overexpression of miR‑338-3p in BC cells significantly inhibited cell proliferation, colony formation, migration and invasion, and induced cell apoptosis and cell cycle arrest at G1/G0 stage, as well as suppressed tumor growth in the nude mouse model. Luciferase assay and western blot analysis identified sex-determining region Y-box 4 (SOX4) as a direct and functional target of miR‑338-3p. These findings revealed that miR‑338-3p may act as a tumor suppressor in breast cancer by targeting SOX4, suggesting miR‑338-3p as a novel strategy for breast cancer treatment.

          Related collections

          Author and article information

          Journal
          Int. J. Oncol.
          International journal of oncology
          Spandidos Publications
          1791-2423
          1019-6439
          Oct 2015
          : 47
          : 4
          Affiliations
          [1 ] Department of Ultrasonography, China-Japan Union Hospital of Jilin University, Nanguan District, Changchun 13033, P.R. China.
          [2 ] Department of Nuclear Medicine, China-Japan Union Hospital of Jilin University, Nanguan District, Changchun 13033, P.R. China.
          [3 ] Department of Oncology and Hematology, China-Japan Union Hospital of Jilin University, Nanguan District, Changchun 13033, P.R. China.
          [4 ] Department of Endocrinology, China-Japan Union Hospital of Jilin University, Nanguan District, Changchun 13033, P.R. China.
          Article
          10.3892/ijo.2015.3114
          26252944

          Comments

          Comment on this article